Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Izzy who wrote (2784)	11/14/1997 3:37:00 PM
From: Izzy	Read Replies (2) of 6136

FWIW, the reason I asked the above questions has to do with yesterday's posts and the AIDS article in today's San Diego paper ("New drug combos fail to hill HIV"). However, the article states: "There's a mistaken notion that the drugs have a certain life span and then run out of steam. It's probably the opposite. The longer people remain on the treatment, the longer they continue to do well...They confirm what we suspected, which is that used appropriately, these drugs probably suppress viral replication to close to zero...if the virus is not reproducing, it cannot mutate, and drug-resistant strains cannot evolve." But there is no mention of Viracept use.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next